Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 3/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SGK1 | O00141 | 3/20 | 0.33 |
| ▸ | CLK2 | P49760 | 1/20 | 0.33 |
| ▸ | HIPK1 | Q86Z02 | 1/20 | 0.33 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.33 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453211 | 0.96 | CYP11B1 (0.38) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL26161267 | 0.94 | CYP11B1 (0.36) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL20176705 | 0.94 | ESR1 (0.40) | ESR1ESR2GRM4NPC1MAPT | |
| SCHEMBL26161172 | 0.94 | ESR1 (0.40) | ESR1ESR2GRM4NPC1MAPT | |
| SCHEMBL26160909 | 0.94 | ESR1 (0.40) | ESR1ESR2GRM4NPC1MAPT | |
| SCHEMBL20176636 | 0.93 | ESR1 (0.40) | ESR1ESR2GRM4NPC1MAPT | |
| SCHEMBL26161377 | 0.92 | ESR1 (0.38) | ESR1ESR2GRM4MAPT | |
| SCHEMBL26160910 | 0.89 | ESR1 (0.40) | CYP11B1CYP11B2ESR1ESR2GRM4 | |
| SCHEMBL16067688 | 0.89 | ESR1 (0.42) | ESR1ESR2NPC1CASP3SENP7 | |
| SCHEMBL26161379 | 0.88 | ESR1 (0.37) | ESR1ESR2GRM4NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| WO-2018093231-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | 주식회사 두산 | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | OR10J3, ICMT, SLCO4C1 | CYP11B1 836/4885CYP11B2 747/4885CYP17A1 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.